Loading
Latest filing published 18 Sept 2026 for Knight Therapeutics Inc., €1,773. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Amal Khouri on record concern Knight Therapeutics Inc. We count 4 filings; the first trade dates from 15 June 2026 and the latest from 15 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 18 September 2026, the filings show a share grant worth €1,773 in Knight Therapeutics Inc. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations